Filing Details
- Accession Number:
- 0000315066-22-001673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-14 17:24:23
- Reporting Period:
- 2022-07-12
- Accepted Time:
- 2022-07-14 17:24:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-12 | 100,000 | $19.98 | 633,729 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Common Stock | Disposition | 2022-07-12 | 63,000 | $22.04 | 570,729 | No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
| No | 4 | S | Indirect | F-Prime Capital Partners Healthcare Fund V LP |
Footnotes
- As the result of a scrivener's error, the Form 4 for Verve Therapeutics Inc. submitted on July 6, 2022, to the Commission for trades that occurred on July 1, 2022, misreported the amount of securities beneficially owned following the reported transactions as 773,729 common shares of Verve Therapeutics. The amount of securities beneficially owned by F-Prime Capital Partners Healthcare Fund V LP as of July 1, 2022 was 733,729 common shares following the disposal of 38,775 common shares.
Billionaire Hedge Funds
